ABSTRACT
BACKGROUND: Structured competency-based training is one of the most frequently articulated wishes of residents. METHODS: A survey of 19 residents was conducted regarding their satisfaction with the resident education at a level 1 trauma center. In this article the development of a revised competency-based education concept was carried out. RESULTS: The survey reflected uncertainty as to whether the current structures could meet the requirements of the residency regulations. The improved competency-based education concept consists of clinical mentoring, competency-based catalogs of learning objectives, regular theoretical and practical workshops as well as regular and structured staff evaluations. CONCLUSION: The education concept presented reflects the attempt to establish a contemporary surgical training program which will be evaluated as it progresses.
Subject(s)
Competency-Based Education , Education, Medical, Continuing , Internship and Residency , Trauma Centers , Humans , Competency-Based Education/methods , Education, Medical, Continuing/methods , Germany , Surveys and Questionnaires , Clinical Competence/standards , Male , Female , Traumatology/education , Personal Satisfaction , Attitude of Health Personnel , AdultABSTRACT
INTRODUCTION: Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS) is the first non-pharmacological multicenter randomized clinical trial (RCT) to prevent cognitive impairment in Latin America (LA). Our aim is to present the study design and discuss the strategies used for multicultural harmonization. METHODS: This 1-year RCT (working on a 1-year extension) investigates the feasibility of a multi-domain lifestyle intervention in LA and the efficacy of the intervention, primarily on cognitive function. An external harmonization process was carried out to follow the FINGER model, and an internal harmonization was performed to ensure this study was feasible and comparable across the 12 participating LA countries. RESULTS: Currently, 1549 participants have been screened, and 815 randomized. Participants are ethnically diverse (56% are Nestizo) and have high cardiovascular risk (39% have metabolic syndrome). DISCUSSION: LatAm-FINGERS overcame a significant challenge to combine the region's diversity into a multi-domain risk reduction intervention feasible across LA while preserving the original FINGER design.
Subject(s)
Cognitive Dysfunction , Humans , Latin America , Cognitive Dysfunction/prevention & control , Life Style , Cognition , Research DesignABSTRACT
Introduction: The historical development, frequency, and impact of frontotemporal dementia (FTD) are less clear in Latin America than in high-income countries. Although there is a growing number of dementia studies in Latin America, little is known collectively about FTD prevalence studies by country, clinical heterogeneity, risk factors, and genetics in Latin American countries. Methods: A systematic review was completed, aimed at identifying the frequency, clinical heterogeneity, and genetics studies of FTD in Latin American populations. The search strategies used a combination of standardized terms for FTD and related disorders. In addition, at least one author per Latin American country summarized the available literature. Collaborative or regional studies were reviewed during consensus meetings. Results: The first FTD reports published in Latin America were mostly case reports. The last two decades marked a substantial increase in the number of FTD research in Latin American countries. Brazil (165), Argentina (84), Colombia (26), and Chile (23) are the countries with the larger numbers of FTD published studies. Most of the research has focused on clinical and neuropsychological features (n = 247), including the local adaptation of neuropsychological and behavioral assessment batteries. However, there are little to no large studies on prevalence (n = 4), biomarkers (n = 9), or neuropathology (n = 3) of FTD. Conclusions: Future FTD studies will be required in Latin America, albeit with a greater emphasis on clinical diagnosis, genetics, biomarkers, and neuropathological studies. Regional and country-level efforts should seek better estimations of the prevalence, incidence, and economic impact of FTD syndromes.
ABSTRACT
Background: Aim of this study was to review current literature and data regarding the effects of MRI-examination post stent implantation on re-occlusion rates.Methods: We focused on representative studies in the database MEDLINE. Inclusion criteria were: clinical studies with the main focus on the safety of coronary artery stents after MRI-examination in the time interval of 8 weeks post stent implantation. During a follow up period the incidence of cardiac events was recorded. In addition, the time interval between stent implantation and MRI-examination should be defined.Results: Our search resulted in a total of relevant 17 studies. There were in-vivo as well as in-vitro studies and in addition three further publications f.e. guidelines. Concerning the patients, we differentiated between MRI performed shortly after acute cardiac event and in stable CAD. MRI-examinations were performed at different field strengths and reported different stent types. Considered were the incidences of cardiac events.Conclusion: Independent of MRI field strength (1.5 Tesla or 3.0 Tesla) or used stent type (BMS or DES), there was no increased rate for cardiac events in patients, who underwent MRI < 8 weeks after stent placement. MRI < 8 weeks after stent placement seems to be safe.
Subject(s)
Coronary Vessels/diagnostic imaging , Magnetic Resonance Imaging , Stents/adverse effects , Coronary Artery Disease , Humans , Treatment OutcomeABSTRACT
INTRODUCTION: A growing number of dominantly inherited Alzheimer's disease (DIAD) cases have become known in Latin American (LatAm) in recent years. However, questions regarding mutation distribution and frequency by country remain open. METHODS: A literature review was completed aimed to provide estimates for DIAD pathogenic variants in the LatAm population. The search strategies were established using a combination of standardized terms for DIAD and LatAm. RESULTS: Twenty-four DIAD pathogenic variants have been reported in LatAm countries. Our combined dataset included 3583 individuals at risk; countries with highest DIAD frequencies were Colombia (n = 1905), Puerto Rico (n = 672), and Mexico (n = 463), usually attributable to founder effects. We found relatively few reports with extensive documentation on biomarker profiles and disease progression. DISCUSSION: Future DIAD studies will be required in LatAm, albeit with a more systematic approach to include fluid biomarker and imaging studies. Regional efforts are under way to extend the DIAD observational studies and clinical trials to Latin America.
Subject(s)
Alzheimer Disease , Genes, Dominant/genetics , Genetic Heterogeneity , Genetic Predisposition to Disease , Phenotype , Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Humans , Latin America/epidemiology , Mutation/geneticsABSTRACT
BACKGROUND & AIMS: The lipid-binding protein, SEC14L2, is crucial for the efficient viral replication of clinical hepatitis C virus (HCV) isolates in cell culture. Given the role of SEC14L2 in HCV replication, we aimed to study a large number of HCV positive sera carrying genotypes 1-4, to identify viral factors associated with efficient replication in culture. Additionally, we investigated whether 13 single nucleotide polymorphisms (SNPs) of SEC14L2 have an impact on RNA replication of naturally occurring HCV isolates. METHODS: We generated Huh-7.5 cell lines overexpressing SEC14L2 or 13 coding SNPs and tested 73 different HCV positive sera for in vitro replication. Furthermore, we genotyped a cohort of 262 patients with chronic HCV for the common SNP (rs757660) and investigated its effect on the clinical phenotype. RESULTS: HCV isolates from genotype 1, 2, 3 and 4 replicate in Huh-7.5 cells overexpressing SEC14L2. Interestingly, only subgenomic replicons from genotypes 1 and 3 showed enhanced replication whereas genotypes 2 and 4 remained unaffected. Furthermore, replication was independent of viral load. Importantly, all tested SNPs supported HCV RNA replication in vitro, while 1 SNP was associated with decreased SEC1L2 expression and viral RNA. All SNPs exhibited comparable cellular cholesterol and vitamin E abundance in naïve Huh-7.5 cells. CONCLUSIONS: This large screen of natural HCV isolates of 4 genotypes underscores the relevance of SEC14L2 as an in vitro HCV host factor. Additionally, SEC14L2 variants appear to recapitulate the wild-type enhancement of HCV replication. Variant rs191341134 showed a decreased effect due to lowered stability, whereas variant rs757660, a high prevalence mutant, showed a similar phenotype to the wild-type. LAY SUMMARY: Until the year 2015, consistent replication of patient-derived isolates of hepatitis C virus (HCV) in an in vitro model remained a limitation in HCV research. In 2015 a group of authors identified a protein named SEC14L2 that enabled the replication of HCV isolates in cell culture. We performed a large screen encompassing 73 isolates of 4 different HCV genotypes. Additionally, we replaced the natural SEC14L2 with 13 different mutants to test if the protein variation significantly altered its HCV replication enhancing functions. We showed that different genotypes of HCV react differently to the presence of this protein and the variants of the protein mimic the behavior of the wild-type.
Subject(s)
Carrier Proteins/metabolism , Genotype , Hepacivirus/genetics , Hepatitis C, Chronic/genetics , Lipoproteins/metabolism , Trans-Activators/metabolism , Virus Replication/genetics , Carrier Proteins/genetics , Cell Line, Tumor , Cohort Studies , Cytosol/metabolism , Hepatitis C, Chronic/pathology , Hepatitis C, Chronic/virology , Humans , Lipoproteins/genetics , Mutant Proteins/metabolism , Phenotype , Polymorphism, Single Nucleotide , Protein Isoforms/genetics , RNA, Viral/genetics , RNA, Viral/isolation & purification , Replicon , Reverse Transcriptase Polymerase Chain Reaction , Trans-Activators/genetics , Transduction, GeneticABSTRACT
Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a phosphoprotein with key functions in regulating viral RNA replication and assembly. Two phosphoisoforms are discriminated by their different apparent molecular weights: a basally phosphorylated (p56) and a hyperphosphorylated (p58) variant. The precise mechanisms governing p58 synthesis and specific functions of the isoforms are poorly understood. Our study aimed at a deeper understanding of determinants involved in p58 synthesis. We analyzed two variants of p56 and p58 of isolate JFH-1 separately by mass spectrometry using an expression model and thereby identified a threonine-rich phosphopeptide exclusively found in the hyperphosphorylated variant. Individual exchange of possible phosphoacceptor sites to phosphoablatant or -mimetic residues had little impact on HCV replication or assembly in cell culture. A phosphospecific antibody recognizing pT242 revealed that this position was indeed phosphorylated only in p58 and depended on casein kinase Iα. Importantly, phosphoablative mutations at positions T244 and S247 abrogated pT242 detection without substantial effects on global p58 levels, whereas mutations in the preceding serine-rich cluster dramatically reduced total p58 levels but had minor impact on pT242 levels, suggesting the existence of distinct subspecies of hyperphosphorylated NS5A. Mass spectrometry analyses of different genotypes showed variable phosphorylation patterns across NS5A and suggested that the threonine-rich region is also phosphorylated at T242 in gt4a and at S249 in gt1a, gt1b, and gt4a. Our data therefore indicate that p58 is not a single homogenously phosphorylated protein species but rather a population of various phosphoisoforms, with high variability between genotypes.IMPORTANCE Hepatitis C virus infections affect 71 million people worldwide and cause severe chronic liver disease. Recently, efficient antiviral therapies have been established, with inhibitors of nonstructural protein NS5A as a cornerstone. NS5A is a central regulator of HCV replication and assembly but is still enigmatic in its molecular functions. It exists in two phosphoisoforms, p56 and p58. We identified a phosphopeptide exclusively found in p58 and analyzed the determinants involved in phosphorylation of this region. We found evidence for very different phosphorylation patterns resulting in p58. These results challenge the concept of p58 being a homogenous species of NS5A molecules phosphorylated at the same positions and argues for at least two independently phosphorylated variants showing the same electrophoretic mobility, likely serving different functions.
Subject(s)
Hepacivirus/physiology , Threonine/metabolism , Viral Nonstructural Proteins/genetics , Viral Nonstructural Proteins/metabolism , Cell Line , Humans , Mass Spectrometry , Mutation , Phosphorylation , Proteomics , Viral Nonstructural Proteins/chemistry , Virus Assembly , Virus ReplicationABSTRACT
Human noroviruses (huNoV) are the most frequent cause of non-bacterial acute gastroenteritis worldwide, particularly genogroup II genotype 4 (GII.4) variants. The viral nonstructural (NS) proteins encoded by the ORF1 polyprotein induce vesical clusters harboring the viral replication sites. Little is known so far about the ultrastructure of these replication organelles or the contribution of individual NS proteins to their biogenesis. We compared the ultrastructural changes induced by expression of norovirus ORF1 polyproteins with those induced upon infection with murine norovirus (MNV). Characteristic membrane alterations induced by ORF1 expression resembled those found in MNV infected cells, consisting of vesicle accumulations likely built from the endoplasmic reticulum (ER) which included single membrane vesicles (SMVs), double membrane vesicles (DMVs) and multi membrane vesicles (MMVs). In-depth analysis using electron tomography suggested that MMVs originate through the enwrapping of SMVs with tubular structures similar to mechanisms reported for picornaviruses. Expression of GII.4 NS1-2, NS3 and NS4 fused to GFP revealed distinct membrane alterations when analyzed by correlative light and electron microscopy. Expression of NS1-2 induced proliferation of smooth ER membranes forming long tubular structures that were affected by mutations in the active center of the putative NS1-2 hydrolase domain. NS3 was associated with ER membranes around lipid droplets (LDs) and induced the formation of convoluted membranes, which were even more pronounced in case of NS4. Interestingly, NS4 was the only GII.4 protein capable of inducing SMV and DMV formation when expressed individually. Our work provides the first ultrastructural analysis of norovirus GII.4 induced vesicle clusters and suggests that their morphology and biogenesis is most similar to picornaviruses. We further identified NS4 as a key factor in the formation of membrane alterations of huNoV and provide models of the putative membrane topologies of NS1-2, NS3 and NS4 to guide future studies.
Subject(s)
Norovirus/physiology , RNA, Viral/metabolism , Viral Nonstructural Proteins/metabolism , Virus Replication/physiology , Animals , Cell Line , Endoplasmic Reticulum/metabolism , Humans , Norovirus/ultrastructure , Proteins/metabolism , Virus Replication/geneticsABSTRACT
BACKGROUND: The foamy viral genome encodes four central purine-rich elements localized in the integrase-coding region of pol. Previously, we have shown that the first two of these RNA elements (A and B) are required for protease dimerization and activation. The D element functions as internal polypurine tract during reverse transcription. Peters et al., described the third element (C) as essential for gag expression suggesting that it might serve as an RNA export element for the unspliced genomic transcript. RESULTS: Here, we analysed env splicing and demonstrate that the described C element composed of three GAA repeats known to bind SR proteins regulates env splicing, thus balancing the amount of gag/pol mRNAs. Deletion of the C element effectively promotes a splice site switch from a newly identified env splice acceptor to the intrinsically strong downstream localised env 3' splice acceptor permitting complete splicing of almost all LTR derived transcripts. We provide evidence that repression of this env splice acceptor is a prerequisite for gag expression. This repression is achieved by the C element, resulting in impaired branch point recognition and SF1/mBBP binding. Separating the branch point from the overlapping purine-rich C element, by insertion of only 20 nucleotides, liberated repression and fully restored splicing to the intrinsically strong env 3' splice site. This indicated that the cis-acting element might repress splicing by blocking the recognition of essential splice site signals. CONCLUSIONS: The foamy viral purine-rich C element regulates splicing by suppressing the branch point recognition of the strongest env splice acceptor. It is essential for the formation of unspliced gag and singly spliced pol transcripts.
Subject(s)
Gene Expression Regulation, Viral , Gene Products, gag/genetics , Genes, env , Genes, pol , Purines/chemistry , Spumavirus/genetics , Genome, Viral , Humans , RNA Splicing , RNA, Viral/geneticsABSTRACT
With a single exception, all isolates of hepatitis C virus (HCV) require adaptive mutations to replicate efficiently in cell culture. Here, we show that a major class of adaptive mutations regulates the activity of a cellular lipid kinase, phosphatidylinositol 4-kinase IIIα (PI4KA). HCV needs to stimulate PI4KA to create a permissive phosphatidylinositol 4-phosphate-enriched membrane microenvironment in the liver and in primary human hepatocytes (PHHs). In contrast, in Huh7 hepatoma cells, the virus must acquire loss-of-function mutations that prevent PI4KA overactivation. This adaptive mechanism is necessitated by increased PI4KA levels in Huh7 cells compared with PHHs, and is conserved across HCV genotypes. PI4KA-specific inhibitors promote replication of unadapted viral isolates and allow efficient replication of patient-derived virus in cell culture. In summary, this study has uncovered a long-sought mechanism of HCV cell-culture adaptation and demonstrates how a virus can adapt to changes in a cellular environment associated with tumorigenesis.
ABSTRACT
OBJECTIVES: Elevated hip fracture incidence is a major public health problem looming to aggravate in industrialized countries due to demographic developments. We report hip fracture incidence and expected future cases from Vorarlberg, the westernmost province of Austria, results potentially representative of Central European populations. METHODS: Crude and standardized hip fracture incidence rates in Vorarlberg 2003-2013 are reported. Based on the age-specific incidence in 2013 or trends 2003-2013, we predict hip fractures till 2050. RESULTS: Female age-standardized hip fracture incidence decreased 2005-2013, whereas for men, the trend was rather unclear. Uncorrected forecasts indicate that by 2050, female and male cases will each have more than doubled from 2015 in all demographic core scenarios. Corrected by incidence trends before 2013, cases are expected to drop among women but rise among men. CONCLUSIONS: We anticipate rising hip fracture numbers in Vorarlberg within the next decades, unless prevention programs that presumably account for decreasing incidence rates, particularly among women since 2005, take further effect to counteract the predicted steady increase due to demographic changes. Concomitantly, augmented endeavors to target the male population by these programs are needed.
Subject(s)
Hip Fractures/epidemiology , Adult , Age Distribution , Aged , Aged, 80 and over , Austria/epidemiology , Female , Humans , Incidence , Male , Middle Aged , Sex DistributionABSTRACT
Small vessel disease (SVD) in the brain manifests in the periventricular and deep white matter and radiographically is described as "leukoaraiosis". It is increasingly recognized as a cause of morbidity from middle age onward and this clinical relevance has paralleled advances in the field of neuroradiology. Overall, SVD is a heterogenous group of vascular disorders that may be asymptomatic, or a harbinger of many conditions that jeopardize brain health. Management and prevention focuses on blood pressure control, lifestyle modification, and symptomatic treatment.
Subject(s)
Cerebrovascular Circulation , Dementia, Vascular/physiopathology , Hypertension/physiopathology , Leukoaraiosis/physiopathology , Memory Disorders/physiopathology , Blood Pressure/drug effects , Dementia, Vascular/etiology , Female , Humans , Hypertension/complications , Leukoaraiosis/complications , Male , Memory Disorders/etiology , Memory Disorders/prevention & control , Microcirculation , Quality of Life , Risk Reduction Behavior , Terminology as TopicABSTRACT
PURPOSE: We aim to derive an internationally applicable data set to improve prescription safety of psychiatric drugs. METHODS: We performed an in-depth analysis of the concordance of prescribing information of 10 key psychiatric drugs across four major drug markets with regard to indications, warnings and precautions, and contraindications. RESULTS: The individual prescribing information covered on average 71.4 ± 30.3% of all named indications, 59.5 ± 17.1% of all potential warnings and precautions and 70.1 ± 24.4% of all applicable contraindications. CONCLUSION: This substantial variation in key prescribing information across countries highlights the need for a better international cooperation and standardization of prescribing information.
Subject(s)
Drug Labeling , Practice Patterns, Physicians' , Psychotropic Drugs/adverse effects , Consensus , Contraindications , Cooperative Behavior , Drug Labeling/standards , Drug Utilization , Europe , Guideline Adherence , Humans , International Cooperation , Patient Safety , Pharmacoepidemiology , Practice Guidelines as Topic , Practice Patterns, Physicians'/standards , Risk Assessment , Risk Factors , United StatesABSTRACT
Reactions of the extremely bulky amido alkali metal complexes, [KL'(η(6)-toluene)], or in situ generated [LiL'] or [LiLâ³] {L'/ Lâ³ = N(Ar*)(SiR(3)), where Ar* = C(6)H(2){C(H)Ph(2)}(2)Me-2,6,4 and R = Me (L') or Ph (Lâ³)} with group 13 metal(I) halides have yielded a series of monomeric metal(I) amide complexes, [ML'] (M = Ga, In, or Tl) and [MLâ³] (M = Ga or Tl), all but one of which have been crystallographically characterized. The results of the crystallographic studies, in combination with computational analyses, reveal that the metal centers in these compounds are one coordinate and do not exhibit any significant intra- or intermolecular interactions, other than their N-M linkages. One of the complexes, [InL'], represents the first example of a one-coordinate indium(I) amide. Attempts to extend this study to the preparation of the analogous aluminum(I) amide, [AlL'], were not successful. Despite this, a range of novel and potentially synthetically useful aluminum(III) halide and hydride complexes were prepared en route to [AlL'], the majority of which were crystallographically characterized. These include the alkali metal aluminate complexes, [L'AlH(2)(µ-H)Li(OEt(2))(2)(THF)] and [{L'Al(µ-H)(3)K}(2)], the neutral amido-aluminum hydride complex, [{L'AlH(µ-H)}(2)], and the aluminum halide complexes, [L'AlBr(2)(THF)] and [L'AlI(2)]. Reaction of the latter two systems with a variety of reducing agents led only to intractable product mixtures.
Subject(s)
Amides/chemistry , Gallium/chemistry , Indium/chemistry , Organometallic Compounds/chemistry , Thallium/chemistry , Aluminum Compounds/chemistry , Crystallography, X-Ray , Ligands , Metals, Alkali/chemistry , Models, Molecular , Molecular Conformation , Organometallic Compounds/chemical synthesisABSTRACT
A high yield synthesis of a new, extremely bulky anionic gallium(I) N-heterocyclic carbene analogue, [(DAB*)Ga:](-) (DAB* = {N(Ar*)C(H)}(2), Ar* = C(6)H(2){C(H)Ph(2)}(2)Me-2,6,4) has been developed and four monomeric sodium complexes of the heterocycle have been crystallographically characterised. The gallium(I) heterocycle has been utilised in the preparations of the heteroleptic zinc and cadmium gallyl complexes, [(DAB*)GaMX(tmeda)] (M = Zn or Cd, X = Br or I), which were crystallographically characterised. In addition, [(DAB*)Ga:](-) was oxidatively coupled to give the diamagnetic digallane(4), [(DAB*)GaGa(DAB*)]. The moderate yield synthesis of the six-membered gallium(I) heterocycle, [((But)MesNacnac)Ga:] ((But)MesNacnac = [(MesNCBu(t))(2)CH](-), Mes = mesityl), is described, and the compound found to be a monomer in the solid state by an X-ray crystallographic analysis. A low yield by-product from this synthesis, [Ga(5)I(4)((But)MesNacnac)(3)], was also isolated and shown by X-ray crystallography to be a rare example of a compound bearing a group 13 metal-metal bonded chain stabilised by ß-diketiminate ligands. A preliminary analysis of the bonding in the compound was carried out using DFT calculations.
ABSTRACT
Reductions of the ß-diketiminato group 14 metal(II) chloride complexes, [((But)MesNacnac)ECl] ((But)MesNacnac = [(MesNCBu(t))(2)CH](-); Mes = mesityl; E = Ge, Sn or Pb), with a magnesium(I) dimer have led to differing outcomes, which include the formation of the first ß-diketiminato group 14 metal(I) dimer, [{((But)MesNacnac)Sn}(2)].
ABSTRACT
The reduction of the bulky amido-germanium(II) chloride complex, LGeCl (L = N(SiMe(3))(Ar*); Ar* = C(6)H(2)Me{C(H)Ph(2)}(2)-4,2,6), with the magnesium(I) dimer, [{((Mes)Nacnac)Mg}(2)] ((Mes)Nacnac = [(MesNCMe)(2)CH](-); Mes = mesityl), afforded LGeGeL, which represents the first example of a digermyne with a Ge-Ge single bond. Computational studies of the compound have highlighted significant electronic differences between it and multiply bonded digermynes. LGeGeL was shown to cleanly activate H(2) in solution or the solid state, at temperatures as low as -10 °C, to give the mixed valence compound, LGeGe(H)(2)L.